Citations (64)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (22)
Jian-Ping Ren, Hao-Long Cong, Li-Jie Gao, Dong-Fang Jiang, Xin-Tong Li, Yun Wang, Jiu-Qiang Wang & Tie-Shan Tang. (2023) Cyclin-dependent kinase 5 negatively regulates antiviral immune response by disrupting myeloid differentiation primary response protein 88 self-association. Virulence 14:1.
Read now
Read now
Heming Lu, Yuying Wu, Xu Liu, Hailan Jiang, Qiang Pang, Luxing Peng, Jinjian Cheng, Shan Deng, Junzhao Gu, Renfeng Zhao, Xiaoxia Hu, Changyi Chen & Jinming Yu. (2018) A prospective study on neoadjuvant chemoradiotherapy plus anti-EGFR monoclonal antibody followed by surgery for locally advanced cervical cancer. OncoTargets and Therapy 11, pages 3785-3792.
Read now
Read now
Kristina Iribarren, Norma Bloy, Aitziber Buqué, Isabelle Cremer, Alexander Eggermont, Wolf Hervé Fridman, Jitka Fucikova, Jérôme Galon, Radek Špíšek, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2016) Trial Watch: Immunostimulation with Toll-like receptor agonists in cancer therapy. OncoImmunology 5:3.
Read now
Read now
Jonathan Pol, Aitziber Buqué, Fernando Aranda, Norma Bloy, Isabelle Cremer, Alexander Eggermont, Philippe Erbs, Jitka Fucikova, Jérôme Galon, Jean-Marc Limacher, Xavier Preville, Catherine Sautès-Fridman, Radek Spisek, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2016) Trial Watch—Oncolytic viruses and cancer therapy. OncoImmunology 5:2.
Read now
Read now
Erika Vacchelli, Fernando Aranda, Norma Bloy, Aitziber Buqué, Isabelle Cremer, Alexander Eggermont, Wolf Hervé Fridman, Jitka Fucikova, Jérôme Galon, Radek Spisek, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2016) Trial Watch—Immunostimulation with cytokines in cancer therapy. OncoImmunology 5:2.
Read now
Read now
Lorenzo Galluzzi, Alexander Eggermont & Guido Kroemer. (2016) Doubling the blockade for melanoma immunotherapy. OncoImmunology 5:1.
Read now
Read now
Thinle Chodon, Richard C. Koya & Kunle Odunsi. (2015) Active Immunotherapy of Cancer. Immunological Investigations 44:8, pages 817-836.
Read now
Read now
Fernando Aranda, Aitziber Buqué, Norma Bloy, Francesca Castoldi, Alexander Eggermont, Isabelle Cremer, Wolf Hervé Fridman, Jitka Fucikova, Jérôme Galon, Radek Spisek, Eric Tartour, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2015) Trial Watch: Adoptive cell transfer for oncological indications. OncoImmunology 4:11.
Read now
Read now
Guido Kroemer & Lorenzo Galluzzi. (2015) Immunotherapy of hematological cancers: PD-1 blockade for the treatment of Hodgkin's lymphoma. OncoImmunology 4:6.
Read now
Read now
Norma Bloy, Aitziber Buqué, Fernando Aranda, Francesca Castoldi, Alexander Eggermont, Isabelle Cremer, Catherine Sautès-Fridman, Jitka Fucikova, Jérôme Galon, Radek Spisek, Eric Tartour, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2015) Trial watch: Naked and vectored DNA-based anticancer vaccines. OncoImmunology 4:5.
Read now
Read now
Lucely Cetina, Tania Crombet, Roberto Jiménez-Lima, Sergio Zapata, Mayra Ramos, Sandra Avila, Jaime Coronel, Eduardo Charco, Rafael Bojalil, Horacio Astudillo, Blanca Bazán & Alfonso Dueñas-González. (2015) A pilot study of nimotuzumab plus single agent chemotherapy as second- or third-line treatment or more in patients with recurrent, persistent or metastatic cervical cancer. Cancer Biology & Therapy 16:5, pages 684-689.
Read now
Read now
Florine Obrist, Gwenola Manic, Guido Kroemer, Ilio Vitale & Lorenzo Galluzzi. (2015) Trial Watch: Proteasomal inhibitors for anticancer therapy. Molecular & Cellular Oncology 2:2.
Read now
Read now
Jonathan Pol, Erika Vacchelli, Fernando Aranda, Francesca Castoldi, Alexander Eggermont, Isabelle Cremer, Catherine Sautès-Fridman, Jitka Fucikova, Jérôme Galon, Radek Spisek, Eric Tartour, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2015) Trial Watch: Immunogenic cell death inducers for anticancer chemotherapy. OncoImmunology 4:4.
Read now
Read now
Aitziber Buqué, Norma Bloy, Fernando Aranda, Francesca Castoldi, Alexander Eggermont, Isabelle Cremer, Wolf Hervé Fridman, Jitka Fucikova, Jérôme Galon, Aurélien Marabelle, Radek Spisek, Eric Tartour, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2015) Trial Watch: Immunomodulatory monoclonal antibodies for oncological indications. OncoImmunology 4:4.
Read now
Read now
Erika Vacchelli, Jonathan Pol, Norma Bloy, Alexander Eggermont, Isabelle Cremer, Wolf Hervé Fridman, Jérôme Galon, Aurélien Marabelle, Holbrook Kohrt, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2015) Trial watch: Tumor-targeting monoclonal antibodies for oncological indications. OncoImmunology 4:1.
Read now
Read now
Lorenzo Galluzzi, Guido Kroemer & Alexander Eggermont. (2014) Novel immune checkpoint blocker approved for the treatment of advanced melanoma. OncoImmunology 3:11.
Read now
Read now
Norma Bloy, Jonathan Pol, Fernando Aranda, Alexander Eggermont, Isabelle Cremer, Wolf Hervé Fridman, Jitka Fučíková, Jérôme Galon, Eric Tartour, Radek Spisek, Madhav V. Dhodapkar, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2014) Trial watch: Dendritic cell-based anticancer therapy. OncoImmunology 3:11.
Read now
Read now
Fernando Aranda, Erika Vacchelli, Florine Obrist, Alexander Eggermont, Jérôme Galon, Catherine Sautès-Fridman, Isabelle Cremer, Jan Henrik ter Meulen, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2014) Trial Watch. OncoImmunology 3:6.
Read now
Read now
Erika Vacchelli, Fernando Aranda, Florine Obrist, Alexander Eggermont, Jérôme Galon, Isabelle Cremer, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2014) Trial watch. OncoImmunology 3:6.
Read now
Read now
Erika Vacchelli, Fernando Aranda, Alexander Eggermont, Jérôme Galon, Catherine Sautès-Fridman, Isabelle Cremer, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2014) Trial Watch. OncoImmunology 3:3.
Read now
Read now
Fernando Aranda, Erika Vacchelli, Alexander Eggermont, Jérôme Galon, Wolf Hervé Fridman, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2014) Trial Watch. OncoImmunology 3:2.
Read now
Read now
Gwenola Manic, Florine Obrist, Guido Kroemer, Ilio Vitale & Lorenzo Galluzzi. (2014) Chloroquine and hydroxychloroquine for cancer therapy. Molecular & Cellular Oncology 1:1.
Read now
Read now
Articles from other publishers (42)
Steffi Tiburcius, Kannan Krishnan, Jae‐Hun Yang, Fatemeh Hashemi, Gurwinder Singh, Deepika Radhakrishnan, Hoang Trung Trinh, Nicole M. Verrills, Ajay Karakoti & Ajayan Vinu. (2020) Silica‐Based Nanoparticles as Drug Delivery Vehicles for Prostate Cancer Treatment. The Chemical Record 21:6, pages 1535-1568.
Crossref
Crossref
Isabel de Lavera, Patrick J. Merkling, José M. Oliva, María J. Sayagués, David Cotán, José A. Sánchez-Alcázar, Juan J. Infante & Ana P. Zaderenko. (2021) EGFR-targeting antitumor therapy: Neuregulins or antibodies?. European Journal of Pharmaceutical Sciences 158, pages 105678.
Crossref
Crossref
Mei Feng, Zhongwei Zhao, Mengxuan Yang, Jiansong Ji & Di Zhu. (2021) T-cell-based immunotherapy in colorectal cancer. Cancer Letters 498, pages 201-209.
Crossref
Crossref
Fleury Augustin Nsole Biteghe, Neelakshi Mungra, Nyangone Ekome Toung Chalomie, Jean De La Croix Ndong, Jean Engohang-Ndong, Guillaume Vignaux, Eden Padayachee, Krupa Naran & Stefan Barth. (2020) Advances in epidermal growth factor receptor specific immunotherapy: lessons to be learned from armed antibodies. Oncotarget 11:38, pages 3531-3557.
Crossref
Crossref
Peter Hollowell, Zongyi Li, Xuzhi Hu, Sean Ruane, Cavan Kalonia, Christopher F. van der Walle & Jian R. Lu. (2020) Recent Advances in Studying Interfacial Adsorption of Bioengineered Monoclonal Antibodies. Molecules 25:9, pages 2047.
Crossref
Crossref
Xiao-xiao Cui, Hong-mei Ding, Fei Gu, Yuan-yuan Lv, Xin Xing & Rong Zhang. (2019) Inhibition of CTHRC-1 by its specific monoclonal antibody attenuates cervical cancer cell metastasis. Biomedicine & Pharmacotherapy 110, pages 758-763.
Crossref
Crossref
Ashanti Concepción Uscanga‐Palomeque, Kenny Misael Calvillo‐Rodríguez, Luis Gómez‐Morales, Eva Lardé, Thomas Denèfle, Diana Caballero‐Hernández, Hélène Merle‐Béral, Santos A. Susin, Philippe Karoyan, Ana Carolina Martínez‐Torres & Cristina Rodríguez‐Padilla. (2018)
CD
47 agonist peptide
PKHB
1 induces immunogenic cell death in T‐cell acute lymphoblastic leukemia cells
. Cancer Science 110:1, pages 256-268.
Crossref
Crossref
Uday Koli, Anomitra Dey, P. Nagendra, Padma V. Devarajan, Ratnesh Jain & Prajakta Dandekar. 2019. Targeted Intracellular Drug Delivery by Receptor Mediated Endocytosis. Targeted Intracellular Drug Delivery by Receptor Mediated Endocytosis
229
268
.
Zongyi Li, Fang PanRuiheng LiElias Pambou, Xuzhi HuSean RuaneDaniela CiumacPeixun LiRebecca J.L. Welbourn, John R.P. WebsterSteven M. Bishop, Rojaramani Narwal, Christopher F. van der Walle & Jian Ren Lu. (2018)
Coadsorption of a Monoclonal Antibody and Nonionic Surfactant at the SiO
2
/Water Interface
. ACS Applied Materials & Interfaces 10:51, pages 44257-44266.
Crossref
Crossref
S. Hameed & Z. Dai. (2018) Near-infrared fluorescence probes for surgical navigation. Materials Today Chemistry 10, pages 90-103.
Crossref
Crossref
Yi-Jun Wang, Rochelle Fletcher, Jian Yu & Lin Zhang. (2018) Immunogenic effects of chemotherapy-induced tumor cell death. Genes & Diseases 5:3, pages 194-203.
Crossref
Crossref
Dipak Barua. (2018) A model-based analysis of tissue targeting efficacy of nanoparticles. Journal of The Royal Society Interface 15:140, pages 20170787.
Crossref
Crossref
Fang PanZongyi LiThomas LeyshonDominic RouseRuiheng LiCharles SmithMario CampanaJohn R. P. WebsterSteven M. Bishop, Rojaramani Narwal, Christopher F. van der Walle, Jim Warwicker & Jian Ren Lu. (2017) Interfacial Adsorption of Monoclonal Antibody COE-3 at the Solid/Water Interface. ACS Applied Materials & Interfaces 10:1, pages 1306-1316.
Crossref
Crossref
D. Dilloo, H. Lode & C. Rössig. 2018. Pädiatrische Hämatologie und Onkologie. Pädiatrische Hämatologie und Onkologie
191
198
.
Richard Nuccitelli, Amanda McDaniel, Snjezana Anand, John Cha, Zachary Mallon, Jon Casey Berridge & Darrin Uecker. (2017) Nano-Pulse Stimulation is a physical modality that can trigger immunogenic tumor cell death. Journal for ImmunoTherapy of Cancer 5:1.
Crossref
Crossref
Brad Bolon & Famke Aeffner. (2017) A Primer for Oncoimmunology (Immunooncology). Toxicologic Pathology 45:5, pages 584-588.
Crossref
Crossref
Ray R. Zhang, Alexandra B. Schroeder, Joseph J. Grudzinski, Eben L. Rosenthal, Jason M. Warram, Anatoly N. Pinchuk, Kevin W. Eliceiri, John S. Kuo & Jamey P. Weichert. (2017) Beyond the margins: real-time detection of cancer using targeted fluorophores. Nature Reviews Clinical Oncology 14:6, pages 347-364.
Crossref
Crossref
Jian-Feng Liu, Si-Rui Ma, Liang Mao, Lin-Lin Bu, Guang-Tao Yu, Yi-Cun Li, Cong-Fa Huang, Wei-Wei Deng, Ashok B. Kulkarni, Wen-Feng Zhang & Zhi-Jun Sun. (2017) T-cell immunoglobulin mucin 3 blockade drives an antitumor immune response in head and neck cancer. Molecular Oncology 11:2, pages 235-247.
Crossref
Crossref
Bo Mi Ku, Yeon-Hee Bae, Jiae Koh, Jong-Mu Sun, Se-hoon Lee, Jin Seok Ahn, Keunchil Park & Myung-Ju Ahn. (2016) AZD9291 overcomes T790 M-mediated resistance through degradation of EGFRL858R/T790M in non-small cell lung cancer cells. Investigational New Drugs 34:4, pages 407-415.
Crossref
Crossref
Lorenzo Galluzzi, Aitziber Buqué & Guido Kroemer. (2016) Prevention of breast cancer by RANKL/RANK blockade. Cell Research 26:7, pages 751-752.
Crossref
Crossref
Junjie Xu & Wenwei Mao. (2016) Overview of Research and Development for Anticancer Drugs. Journal of Cancer Therapy 07:10, pages 762-772.
Crossref
Crossref
Gregory T. Wurz, Chiao-Jung Kao & Michael W. DeGregorio. (2015) Novel cancer antigens for personalized immunotherapies: latest evidence and clinical potential. Therapeutic Advances in Medical Oncology 8:1, pages 4-31.
Crossref
Crossref
Monica Benvenuto, Pierpaolo Sileri, Piero Rossi, Laura Masuelli, Massimo Fantini, Monica Nanni, Luana Franceschilli, Giuseppe Sconocchia, Giulia Lanzilli, Roberto Arriga, Giovanni Faggioni, Florigio Lista, Augusto Orlandi, Vittorio Manzari, Achille Lucio Gaspari, Andrea Modesti & Roberto Bei. (2015) Natural humoral immune response to ribosomal P0 protein in colorectal cancer patients. Journal of Translational Medicine 13:1.
Crossref
Crossref
Lorenzo Galluzzi, Aitziber Buqué, Oliver Kepp, Laurence Zitvogel & Guido Kroemer. (2015) Immunological Effects of Conventional Chemotherapy and Targeted Anticancer Agents. Cancer Cell 28:6, pages 690-714.
Crossref
Crossref
Katie Anderson & Jaime Modiano. (2015) Progress in Adaptive Immunotherapy for Cancer in Companion Animals: Success on the Path to a Cure. Veterinary Sciences 2:4, pages 363-387.
Crossref
Crossref
Cédric Rébé & François Ghiringhelli. (2015) Cytotoxic effects of chemotherapy on cancer and immune cells: how can it be modulated to generate novel therapeutic strategies?. Future Oncology 11:19, pages 2645-2654.
Crossref
Crossref
L. Apetoh, S. Ladoire, G. Coukos & F. Ghiringhelli. (2015) Combining immunotherapy and anticancer agents: the right path to achieve cancer cure?. Annals of Oncology 26:9, pages 1813-1823.
Crossref
Crossref
Patrick Dennler, Eliane Fischer & Roger Schibli. (2015) Antibody Conjugates: From Heterogeneous Populations to Defined Reagents. Antibodies 4:3, pages 197-224.
Crossref
Crossref
Laurence Zitvogel, Lorenzo Galluzzi, Oliver Kepp, Mark J. Smyth & Guido Kroemer. (2015) Type I interferons in anticancer immunity. Nature Reviews Immunology 15:7, pages 405-414.
Crossref
Crossref
Zhi-Ying Chen, Fei Ma, Hailiang Huang & Cheng-Yi He. (2015) Synthetic immunity to break down the bottleneck of cancer immunotherapy. Science Bulletin 60:11, pages 977-985.
Crossref
Crossref
David Sánchez-Martín, Morten Dræby Sørensen, Simon Lykkemark, Laura Sanz, Peter Kristensen, Erkki Ruoslahti & Luis Álvarez-Vallina. (2015) Selection strategies for anticancer antibody discovery: searching off the beaten path. Trends in Biotechnology 33:5, pages 292-301.
Crossref
Crossref
Alexander M. LesokhinMargaret K. CallahanMichael A. PostowJedd D. Wolchok. (2015) On being less tolerant: Enhanced cancer immunosurveillance enabled by targeting checkpoints and agonists of T cell activation. Science Translational Medicine 7:280.
Crossref
Crossref
Maria Vela, Mariana Aris, Mercedes Llorente, Jose A. Garcia-Sanz & Leonor Kremer. (2015) Chemokine Receptor-Specific Antibodies in Cancer Immunotherapy: Achievements and Challenges. Frontiers in Immunology 6.
Crossref
Crossref
Jean-François Rossi. (2015) Targeted Therapies in Adult B-Cell Malignancies. BioMed Research International 2015, pages 1-16.
Crossref
Crossref
Marilena Tauro, Jeremy McGuire & Conor C. Lynch. (2014) New approaches to selectively target cancer-associated matrix metalloproteinase activity. Cancer and Metastasis Reviews 33:4, pages 1043-1057.
Crossref
Crossref
J. Tykvart, V. Navrátil, F. Sedlák, E. Corey, M. Colombatti, G. Fracasso, F. Koukolík, C. Bařinka, P. Šácha & J. Konvalinka. (2014) Comparative analysis of monoclonal antibodies against prostate-specific membrane antigen (PSMA). The Prostate 74:16, pages 1674-1690.
Crossref
Crossref
Wouter Scheper, Zsolt Sebestyen & Jürgen Kuball. (2014) Cancer Immunotherapy Using γδT Cells: Dealing with Diversity. Frontiers in Immunology 5.
Crossref
Crossref
JENNIE ANDERSSON, MARIA ROSESTEDT, VERONIKA ASPLUND, NAZILA YAVARI & ANNA ORLOVA. (2014) In vitro modeling of HER2-targeting therapy in disseminated prostate cancer. International Journal of Oncology 45:5, pages 2153-2158.
Crossref
Crossref
Donald J. Scholten, Christine M. Timmer, Jacqueline D. Peacock, Dominic W. Pelle, Bart O. Williams & Matthew R. Steensma. (2014) Down Regulation of Wnt Signaling Mitigates Hypoxia-Induced Chemoresistance in Human Osteosarcoma Cells. PLoS ONE 9:10, pages e111431.
Crossref
Crossref
V. Grünwald & M. Rickmann. (2014) Arzneitherapie solider TumorenPharmacotherapy of solid tumors. Der Internist 55:10, pages 1220-1227.
Crossref
Crossref
Carla Casulo, Julie M. Vose, William Y. Ho, Brad Kahl, Mark Brunvand, Andre Goy, Yvette Kasamon, Bruce Cheson & Jonathan W. Friedberg. (2014) A phase I study of PRO131921, a novel anti-CD20 monoclonal antibody in patients with relapsed/refractory CD20+ indolent NHL: Correlation between clinical responses and AUC pharmacokinetics. Clinical Immunology 154:1, pages 37-46.
Crossref
Crossref
E. Vaccheli, J. Michels, J. Hadoux & J. P. Lotz. (2014) American association for cancer research — AACR congress 2014Congrès de l’association américaine de recherche contre le cancer — AACR 2014. Oncologie 16:7-8, pages 341-366.
Crossref
Crossref